Immunogen: Q4 Earnings Insights

Immunogen: Q4 Earnings Insights


Immunogen IMGN reported its Q4 earnings results on Friday, February 25, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.


Immunogen reported an EPS of $-0.17.

Revenue was up $57.81 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 1.86% increase in the share price the next day.

Here's a look at Immunogen's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.18 -0.18 -0.19 -0.08
EPS Actual -0.18 -0.15 -0.17 0.16
Revenue Estimate 19.03M 18.92M 17.73M 40.83M
Revenue Actual 9.21M 16.95M 15.71M 85.80M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews